查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2037530

寵物診斷市場預測—全球產品類型、動物種類、技術、應用、最終用戶、通路和地區分析—2034年

Pet Diagnostics Market Forecasts to 2034 - Global Analysis By Product, Animal Type (Dogs, Cats, Horses, and Other Companion Animals), Technology, Application, End User, Distribution Channel, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

全球寵物診斷市場預計到 2026 年將達到 130 億美元，並在預測期內以 10.4% 的複合年成長率成長，到 2034 年達到 287 億美元。

寵物診斷市場涵蓋一系列全面的檢測解決方案，用於輔助伴侶動物的疾病檢測、健康監測和治療方案。這些工具包括臨床化學分析儀、血液學系統、免疫檢測平台、分子診斷和先進成像系統。寵物日益「人性化」、寵物醫療保健成本不斷上漲以及動物慢性病盛行率的上升，正推動全球獸醫醫院、實驗室和動物醫院對準確、快速診斷解決方案的需求。

寵物數量的增加以及寵物“擬人化”

在全球範圍內，越來越多的飼主將寵物視為家庭成員，因此他們更願意為寵物提供先進的診斷服務。這種情感連結促使寵物主人更頻繁地光顧獸醫診所，增加預防性篩檢的頻率，並接受以往僅限於人類醫學的先進檢測方案。如今，寵物飼主期望寵物也能像自己一樣獲得精準的診斷，包括疾病的早期發現和全面的健康監測。這一趨勢在可支配收入較高且寵物擁有率持續上升的都市區尤為顯著，從而對所有診斷產品類型都產生了持續的需求。

先進診斷設備高成本

分子診斷系統和影像設備需要大量的資金投入，這限制了它們的普及，尤其對於小規模的獸醫診所。雖然這些先進設備能夠提供更高的準確性和更快的檢測結果，但考慮到患者數量，其價格對於許多獨立經營的獸醫診所來說難以負擔。此外，維護、校準和操作人員培訓等額外費用也進一步加重了診所的預算負擔。這些經濟壓力導致醫療產業出現整合趨勢，而公司旗下的診所更有能力承擔這些成本。這種差距造成了市場兩極化：先進的診斷技術集中在專業的都市區中心，而鄉村診所則依賴基礎設備和外部實驗室。

擴展即時診斷解決方案

攜帶式和桌上型分析儀能夠在一次就診中快速提供檢測結果，正在改變獸醫學。這些緊湊型系統消除了將檢體送到外部實驗室所帶來的延誤，使臨床決策能夠即時，並改善治療效果。微流體和微型光學技術的創新使得從生物化學和血液學到分子診斷的即時檢測成為可能。對於飼主，更快的檢測結果可以減輕焦慮，減少就診次數。對於獸醫而言，這提高了工作效率，並增加了每次診療的收入。隨著技術成本的降低和準確性的提高，即時診斷有望在各種規模的動物醫院中廣泛應用。

訓練有素的獸醫專業人員短缺

熟練先進診斷設備操作技能的獸醫和獸醫技師短缺，限制了市場成長，尤其是在新興國家。即使診所投資購買了先進的分析設備，由於缺乏能夠準確進行檢測和解讀結果的訓練有素的人員，這些設備也無法充分利用。隨著寵物數量的增加和在職獸醫的退休，全球獸醫專業人員短缺的問題預計將會加劇。如果沒有完善的培訓體系，先進診斷技術的潛力將無法充分發揮，這可能導致檢測服務集中到中央實驗室，並減少單一診所安裝的設備數量。

新型冠狀病毒（COVID-19）的影響：

疫情初期，診所關閉和常規就診量下降對寵物診斷市場造成了衝擊，但隨後，在疫情期間寵物領養數量激增的推動下，市場強勁復甦。封鎖措施導致寵物領養率空前高漲，擴大了長期病患群體。儘管供應鏈挑戰影響了試劑和耗材的供應，但遠距遠端醫療的普及為檢測申請和結果交付創建了新的工作流程。疫情加速了獸醫診斷領域的數位轉型，使基於雲端的數據管理和遠端結果存取成為標準配置。整體而言，疫情促進了寵物醫療保健市場的發展。在隔離期間，飼主將寵物的健康放在首位，為市場的持續成長奠定了基礎。

在預測期內，耗材細分市場預計將佔據最大的市場佔有率。

在預測期內，耗材領域預計將佔據最大的市場佔有率，這主要得益於對試劑、檢測套組和檢體採集用品的持續需求。每進行一次診斷測試都需要新的耗材，從而創造了可預測且可重複的收入來源，其價值遠遠超出一次性購買耐用設備。獸醫診所每月進行數百甚至數千次測試，持續不斷產生對這些耗材的需求。此外，耗材通常依賴供應商，因此醫療機構在設備部署後往往會維持長期的採購關係。診斷測試數量的增加，加上測試項目的擴展和處理能力的提升，必將確保耗材領域繼續保持其市場主導地位。

在預測期內，貓科動物細分市場預計將呈現最高的複合年成長率。

在預測期內，貓科動物市場預計將呈現最高的成長率。這反映了全球寵物貓數量的快速成長以及貓科動物特有的診斷挑戰。由於貓特別擅長隱藏疾病症狀，定期診斷篩檢對於早期發現疾病至關重要。慢性腎臟病、甲狀腺功能亢進和糖尿病等慢性疾病的日益普遍，增加了重複檢測的需求。此外，獸醫學的進步正使人們對貓科動物特有的生物標記和參考範圍有更深入的了解，從而實現更準確的診斷。隨著貓飼主越來越重視預防保健，以及年輕一代將貓作為寵物，對貓科動物專用診斷解決方案的需求正在顯著成長。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這得益於其高寵物擁有率、先進的獸醫基礎設施以及在伴侶動物醫療費用支出。該地區受益於完善的寵物保險報銷體系，其寵物保險滲透率高於全球任何其他市場。主要的診斷設備製造商總部均設在北美，確保了新技術和耗材的快速取得。遍佈各地的企業化獸醫院集團，在數百家動物醫院中統一採用標準化的診斷流程，建構了高效的通路。再加上預防性寵物護理的理念和較高的可支配收入，北美將繼續保持其領先地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於不斷壯大的中產階級寵物擁有率的上升以及人們對先進獸醫診斷技術的日益了解。包括中國、印度和東南亞國家在內的地區正在經歷快速的都市化進程，人們對寵物照顧的態度也在轉變，動物正從單純的勞動力或流浪動物轉變為備受珍視的家庭成員。政府為促進動物健康和疾病監測（特別是狂犬病控制和通用感染疾病預防）而採取的舉措，正在推動診斷基礎設施的發展。國際製造商正在建立本地夥伴關係和分銷網路，以滿足這一不斷成長的市場需求。隨著獸醫教育的進步和專業診所的湧現，亞太地區有望成為成長最快的地區。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球寵物診斷市場：依產品分類

  • 裝置
    • 臨床化學分析儀
    • 血液分析儀
    • 免疫檢測裝置
    • 分子診斷系統
    • 影像系統
  • 消耗品
    • 試劑和試劑盒
    • 檢查面板和條
    • 檢體採集耗材
  • 服務
    • 檢查外包服務
    • 診斷軟體和數據管理

第6章：全球寵物診斷市場：依動物類型分類

  • 狗
  • 貓
  • 馬（馬）
  • 其他伴侶動物

第7章：全球寵物診斷市場：依技術分類

  • 臨床生物化學
  • 免疫診斷
  • 分子診斷
  • 血液學
  • 診斷影像
  • 其他技術

第8章：全球寵物診斷市場：按應用分類

  • 傳染病檢查
  • 非傳染病檢查
  • 基因檢測
  • 腫瘤診斷
  • 定期健康檢查

第9章：全球寵物診斷市場：依最終用戶分類

  • 獸醫醫院和診所
  • 診斷檢查室
  • 研究機構
  • 照護端環境

第10章：全球寵物診斷市場：依通路分類

  • 直銷
  • 銷售代理商和批發商
  • 線上管道

第11章 全球寵物診斷市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第12章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第13章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第14章：公司簡介

  • IDEXX Laboratories Inc.
  • Zoetis Inc.
  • Thermo Fisher Scientific Inc.
  • Heska Corporation
  • Virbac
  • Neogen Corporation
  • BioNote Inc.
  • Randox Laboratories Ltd.
  • FUJIFILM Holdings Corporation
  • Abaxis Inc.
  • Mindray Medical International Limited
  • Eurofins Scientific
  • Agrolabo SpA
  • Antech Diagnostics Inc.
  • Biochek BV
  • INDICAL Bioscience GmbH
  • VetScan
  • Bionote USA Inc.
Product Code: SMRC35945

According to Stratistics MRC, the Global Pet Diagnostics Market is accounted for $13.0 billion in 2026 and is expected to reach $28.7 billion by 2034 growing at a CAGR of 10.4% during the forecast period. Pet diagnostics encompass a comprehensive range of testing solutions used to detect diseases, monitor health conditions, and guide treatment decisions for companion animals. These tools include clinical chemistry analyzers, hematology systems, immunoassay platforms, molecular diagnostic devices, and advanced imaging systems. The increasing humanization of pets, rising pet healthcare expenditure, and growing prevalence of chronic diseases in animals are driving demand for accurate and rapid diagnostic solutions across veterinary clinics, reference laboratories, and animal hospitals worldwide.

Market Dynamics:

Driver:

Rising pet ownership and humanization of pets

Growing numbers of pet owners worldwide are treating their animals as family members, leading to increased willingness to spend on advanced diagnostic services. This emotional bond translates into higher veterinary visits, more frequent preventive screenings, and acceptance of sophisticated testing protocols previously reserved for human medicine. Pet owners now demand the same level of diagnostic precision for their animals that they expect for themselves, including early disease detection and comprehensive health monitoring. The trend is particularly pronounced in urban areas where disposable incomes are higher and pet adoption rates continue climbing, creating sustained demand across all diagnostic product categories.

Restraint:

High cost of advanced diagnostic equipment

Significant capital investment required for instruments such as molecular diagnostic systems and imaging equipment limits adoption, particularly in smaller veterinary practices. These sophisticated devices, while offering superior accuracy and faster results, carry price tags that many independent clinics cannot justify given their patient volumes. Additional costs for maintenance, calibration, and operator training further strain budgets. The economic pressure has led to consolidation in the veterinary sector, with corporate-owned practices better positioned to absorb these expenses. This disparity creates a two-tier market where advanced diagnostics remain concentrated in urban specialty centers while rural practices rely on basic equipment or external reference laboratories.

Opportunity:

Expansion of point-of-care diagnostic solutions

Portable and benchtop analyzers capable of delivering rapid results during a single patient visit are transforming veterinary medicine. These compact systems eliminate the delay of sending samples to external laboratories, enabling immediate clinical decision-making and improving treatment outcomes. Innovations in microfluidics and miniaturized optics have made point-of-care testing feasible for chemistry, hematology, and even molecular applications. For pet owners, faster results reduce anxiety and multiple visits; for practitioners, it increases efficiency and revenue per appointment. As technology costs decrease and accuracy improves, point-of-care diagnostics are poised for significant penetration across all veterinary practice sizes.

Threat:

Shortage of trained veterinary professionals

Limited availability of skilled veterinarians and veterinary technicians capable of operating advanced diagnostic equipment constrains market growth, particularly in emerging economies. Even when clinics purchase sophisticated analyzers, lack of trained personnel to perform tests accurately and interpret results leads to underutilization of equipment. The global shortage of veterinary professionals is projected to worsen as pet populations grow and existing practitioners retire. Without adequate training infrastructure, the full potential of advanced diagnostics cannot be realized, potentially driving consolidation of testing services into centralized laboratories and reducing the installed base of instruments across individual practices.

Covid-19 Impact:

The pandemic initially disrupted pet diagnostics through clinic closures and reduced routine visits, but this was followed by a strong rebound driven by pandemic pet adoptions. Lockdowns led to unprecedented pet acquisition rates, expanding the long-term patient base. Supply chain challenges affected reagent and consumable availability, while telemedicine adoption created new workflows for diagnostic ordering and result communication. The crisis accelerated digital transformation in veterinary diagnostics, with cloud-based data management and remote result access becoming standard expectations. Overall, the pandemic strengthened the pet healthcare market as owners valued their companions' health during isolation, establishing durable growth momentum.

The Consumables segment is expected to be the largest during the forecast period

The Consumables segment is expected to account for the largest market share during the forecast period, driven by the recurring nature of reagents, test kits, and sample collection supplies. Each diagnostic test performed requires fresh consumables, creating predictable and continuous revenue streams that surpass the one-time purchase of durable instruments. Veterinary clinics performing hundreds to thousands of tests monthly generate ongoing demand for these supplies. Additionally, consumables are vendor-specific in many cases, locking facilities into long-term purchasing relationships after instrument acquisition. The growing volume of diagnostic testing, combined with expansion of test menus and higher throughput, ensures consumables maintain their dominant market position.

The Cats (Feline) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Cats (Feline) segment is predicted to witness the highest growth rate, reflecting rapidly increasing cat ownership globally and the unique diagnostic challenges felines present. Cats are particularly skilled at hiding illness symptoms, making routine diagnostic screening essential for early disease detection. The rising prevalence of chronic feline conditions, including chronic kidney disease, hyperthyroidism, and diabetes, drives repeat testing requirements. Veterinary medicine has also advanced understanding of feline-specific biomarkers and reference ranges, enabling more accurate diagnostics. As cat owners increasingly embrace preventive healthcare and younger generations prioritize feline companions, demand for specialized feline diagnostic solutions accelerates substantially.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by high pet ownership rates, advanced veterinary infrastructure, and substantial healthcare spending on companion animals. The region benefits from strong reimbursement options through pet insurance, which has higher penetration than any other global market. Major diagnostic manufacturers are headquartered in North America, ensuring rapid access to new technologies and consumables. The prevalence of corporate-owned veterinary consolidators, which standardize diagnostic protocols across hundreds of clinics, creates efficient distribution channels. Combined with a culture of preventive pet healthcare and high disposable incomes, North America maintains its leadership position.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, fueled by rising pet ownership among expanding middle classes and increasing awareness of advanced veterinary diagnostics. Countries including China, India, and Southeast Asian nations are witnessing rapid urbanization and shifting attitudes toward pet care, with animals transitioning from working or stray roles to cherished family members. Government initiatives promoting animal health and disease surveillance, particularly for rabies control and zoonotic disease prevention, support diagnostic infrastructure development. International manufacturers are establishing local partnerships and distribution networks to serve this growing market. As veterinary education improves and specialty practices emerge, Asia Pacific becomes the fastest-growing region.

Key players in the market

Some of the key players in Pet Diagnostics Market include Petmate, MidWest Homes for Pets, Go Pet Club, Ware Pet Products, Prevue Pet Products, Merry Products, PawHut, Trixie Heimtierbedarf GmbH, North American Pet Products, PetPals Group Inc., Armarkat, Furhaven Pet Products, PetFusion LLC, The Refined Feline, Designer Pet Products, Bowsers Pet Products, Enchanted Home Pet, and Critter Couch Company.

Key Developments:

In March 2026, Petmate unveiled its 2026 innovation lineup at the Global Pet Expo, debuting the "Ultra Cannon" automatic fetch system, the "Quirky Kitty Ocean Cool" cooling line for immersive enrichment, and an expansion of its "Wild Eats" collagen treat line with new venison varieties.

In June 2025, DARRAN Furniture launched the "Central Bark" collection, a specialized line of pet beds designed for service animals in modern workplaces, influencing the professional-grade pet furniture standards for players like MidWest Homes for Pets.

In November 2025, Trixie officially partnered with 3P Logistics to manage its expanding UK market growth, aiming to streamline supply chain operations and increase the availability of its lifestyle products in British retail outlets.

Products Covered:

  • Instruments
  • Consumables
  • Services

Animal Types Covered:

  • Dogs (Canine)
  • Cats (Feline)
  • Horses (Equine)
  • Other Companion Animals

Technologies Covered:

  • Clinical Biochemistry
  • Immunodiagnostics
  • Molecular Diagnostics
  • Hematology
  • Diagnostic Imaging
  • Other Technologies

Applications Covered:

  • Infectious Disease Testing
  • Non-Infectious Disease Testing
  • Genetic Testing
  • Oncology Diagnostics
  • Routine Health Screening

End Users Covered:

  • Veterinary Hospitals & Clinics
  • Diagnostic Laboratories
  • Research Institutes
  • Point-of-Care Settings

Distribution Channels Covered:

  • Direct Sales
  • Distributors & Wholesalers
  • Online Channels

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Pet Diagnostics Market, By Product

  • 5.1 Instruments
    • 5.1.1 Clinical Chemistry Analyzers
    • 5.1.2 Hematology Analyzers
    • 5.1.3 Immunoassay Analyzers
    • 5.1.4 Molecular Diagnostic Systems
    • 5.1.5 Imaging Systems
  • 5.2 Consumables
    • 5.2.1 Reagents & Kits
    • 5.2.2 Test Panels & Strips
    • 5.2.3 Sample Collection Consumables
  • 5.3 Services
    • 5.3.1 Reference Laboratory Services
    • 5.3.2 Diagnostic Software & Data Management

6 Global Pet Diagnostics Market, By Animal Type

  • 6.1 Dogs (Canine)
  • 6.2 Cats (Feline)
  • 6.3 Horses (Equine)
  • 6.4 Other Companion Animals

7 Global Pet Diagnostics Market, By Technology

  • 7.1 Clinical Biochemistry
  • 7.2 Immunodiagnostics
  • 7.3 Molecular Diagnostics
  • 7.4 Hematology
  • 7.5 Diagnostic Imaging
  • 7.6 Other Technologies

8 Global Pet Diagnostics Market, By Application

  • 8.1 Infectious Disease Testing
  • 8.2 Non-Infectious Disease Testing
  • 8.3 Genetic Testing
  • 8.4 Oncology Diagnostics
  • 8.5 Routine Health Screening

9 Global Pet Diagnostics Market, By End User

  • 9.1 Veterinary Hospitals & Clinics
  • 9.2 Diagnostic Laboratories
  • 9.3 Research Institutes
  • 9.4 Point-of-Care Settings

10 Global Pet Diagnostics Market, By Distribution Channel

  • 10.1 Direct Sales
  • 10.2 Distributors & Wholesalers
  • 10.3 Online Channels

11 Global Pet Diagnostics Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 IDEXX Laboratories Inc.
  • 14.2 Zoetis Inc.
  • 14.3 Thermo Fisher Scientific Inc.
  • 14.4 Heska Corporation
  • 14.5 Virbac
  • 14.6 Neogen Corporation
  • 14.7 BioNote Inc.
  • 14.8 Randox Laboratories Ltd.
  • 14.9 FUJIFILM Holdings Corporation
  • 14.10 Abaxis Inc.
  • 14.11 Mindray Medical International Limited
  • 14.12 Eurofins Scientific
  • 14.13 Agrolabo S.p.A.
  • 14.14 Antech Diagnostics Inc.
  • 14.15 Biochek BV
  • 14.16 INDICAL Bioscience GmbH
  • 14.17 VetScan
  • 14.18 Bionote USA Inc.

List of Tables

  • 1 Global Pet Diagnostics Market Outlook, By Region (2023-2034) ($MN)
  • 2 Global Pet Diagnostics Market Outlook, By Product (2023-2034) ($MN)
  • 3 Global Pet Diagnostics Market Outlook, By Instruments (2023-2034) ($MN)
  • 4 Global Pet Diagnostics Market Outlook, By Clinical Chemistry Analyzers (2023-2034) ($MN)
  • 5 Global Pet Diagnostics Market Outlook, By Hematology Analyzers (2023-2034) ($MN)
  • 6 Global Pet Diagnostics Market Outlook, By Immunoassay Analyzers (2023-2034) ($MN)
  • 7 Global Pet Diagnostics Market Outlook, By Molecular Diagnostic Systems (2023-2034) ($MN)
  • 8 Global Pet Diagnostics Market Outlook, By Imaging Systems (2023-2034) ($MN)
  • 9 Global Pet Diagnostics Market Outlook, By Consumables (2023-2034) ($MN)
  • 10 Global Pet Diagnostics Market Outlook, By Reagents & Kits (2023-2034) ($MN)
  • 11 Global Pet Diagnostics Market Outlook, By Test Panels & Strips (2023-2034) ($MN)
  • 12 Global Pet Diagnostics Market Outlook, By Sample Collection Consumables (2023-2034) ($MN)
  • 13 Global Pet Diagnostics Market Outlook, By Services (2023-2034) ($MN)
  • 14 Global Pet Diagnostics Market Outlook, By Reference Laboratory Services (2023-2034) ($MN)
  • 15 Global Pet Diagnostics Market Outlook, By Diagnostic Software & Data Management (2023-2034) ($MN)
  • 16 Global Pet Diagnostics Market Outlook, By Animal Type (2023-2034) ($MN)
  • 17 Global Pet Diagnostics Market Outlook, By Dogs (Canine) (2023-2034) ($MN)
  • 18 Global Pet Diagnostics Market Outlook, By Cats (Feline) (2023-2034) ($MN)
  • 19 Global Pet Diagnostics Market Outlook, By Horses (Equine) (2023-2034) ($MN)
  • 20 Global Pet Diagnostics Market Outlook, By Other Companion Animals (2023-2034) ($MN)
  • 21 Global Pet Diagnostics Market Outlook, By Technology (2023-2034) ($MN)
  • 22 Global Pet Diagnostics Market Outlook, By Clinical Biochemistry (2023-2034) ($MN)
  • 23 Global Pet Diagnostics Market Outlook, By Immunodiagnostics (2023-2034) ($MN)
  • 24 Global Pet Diagnostics Market Outlook, By Molecular Diagnostics (2023-2034) ($MN)
  • 25 Global Pet Diagnostics Market Outlook, By Hematology (2023-2034) ($MN)
  • 26 Global Pet Diagnostics Market Outlook, By Diagnostic Imaging (2023-2034) ($MN)
  • 27 Global Pet Diagnostics Market Outlook, By Other Technologies (2023-2034) ($MN)
  • 28 Global Pet Diagnostics Market Outlook, By Application (2023-2034) ($MN)
  • 29 Global Pet Diagnostics Market Outlook, By Infectious Disease Testing (2023-2034) ($MN)
  • 30 Global Pet Diagnostics Market Outlook, By Non-Infectious Disease Testing (2023-2034) ($MN)
  • 31 Global Pet Diagnostics Market Outlook, By Genetic Testing (2023-2034) ($MN)
  • 32 Global Pet Diagnostics Market Outlook, By Oncology Diagnostics (2023-2034) ($MN)
  • 33 Global Pet Diagnostics Market Outlook, By Routine Health Screening (2023-2034) ($MN)
  • 34 Global Pet Diagnostics Market Outlook, By End User (2023-2034) ($MN)
  • 35 Global Pet Diagnostics Market Outlook, By Veterinary Hospitals & Clinics (2023-2034) ($MN)
  • 36 Global Pet Diagnostics Market Outlook, By Diagnostic Laboratories (2023-2034) ($MN)
  • 37 Global Pet Diagnostics Market Outlook, By Research Institutes (2023-2034) ($MN)
  • 38 Global Pet Diagnostics Market Outlook, By Point-of-Care Settings (2023-2034) ($MN)
  • 39 Global Pet Diagnostics Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • 40 Global Pet Diagnostics Market Outlook, By Direct Sales (2023-2034) ($MN)
  • 41 Global Pet Diagnostics Market Outlook, By Distributors & Wholesalers (2023-2034) ($MN)
  • 42 Global Pet Diagnostics Market Outlook, By Online Channels (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.